Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

GlaxoSmithKline plc (GSK)

41.18   0.28 (0.68%) 07-16 16:02
Open: 41.49 Pre. Close: 40.9
High: 41.49 Low: 41.09
Volume: 2,796,598 Market Cap: 103450M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.191 - 41.394 41.394 - 41.599
Low: 40.286 - 40.499 40.499 - 40.716
Close: 40.561 - 40.895 40.895 - 41.234

Technical analysis

as of: 2019-07-16 3:21:16 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 48.46     One year: 56.60
Support: Support1: 40.43    Support2: 39.77
Resistance: Resistance1: 41.49    Resistance2: 48.46
Pivot: 40.67
Moving Average: MA(5): 40.90     MA(20): 40.63
MA(100): 40.36     MA(250): 40.03
MACD: MACD(12,26): 0.26     Signal(9): 0.24
Stochastic oscillator: %K(14,3): 61.62     %D(3): 61.32
RSI: RSI(14): 57.76
52-week: High: 42.32  Low: 36.41  Change(%):
Average Vol(K): 3-Month: 239563  10-Days: 265191

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
GSK has closed below upper band by 20.0%. Bollinger Bands are 12% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 15 Jul 2019 15:19:06 Z
Gilead-Galapagos Ink $5.1B Deal for Additional Compounds

Thu, 11 Jul 2019 00:10:56 Z
Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill

Tue, 09 Jul 2019 16:12:47 Z
Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status

Fri, 05 Jul 2019 20:15:12 Z
Health Care Sector Update for 07/05/2019: TYME,ACER,MOR,GSK,CYTX

Fri, 05 Jul 2019 18:15:24 Z
Health Care Sector Update for 07/05/2019: ACER,MOR,GSK,CYTX

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2490.00
Shares Float (M) 2440.00
% Held by Insiders 0.01
% Held by Institutions 11.00
Shares Short (K) 5730
Shares Short P. Month (K)

Stock Financials

EPS 0.990
EPS Est. Current Year 2.890
EPS Est. Next Year 2.850
EPS Est. Next Quarter
Forward EPS 2.930
Book Value (p.s.) 2.410
PEG Ratio 1.60
Profit Margin 12.49
Operating Margin
Return on Assets (ttm) 8.3
Return on Equity (ttm) 122.7
Qtrly Rev. Growth 6.1
Gross Profit (p.s.) 8.478
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 51.20
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 41.57
P/E Growth Ratio 0.01
P/BV 17.08
P/S
P/CF

Dividends & Splits

Dividend 1.060
Dividend Yield 0.03
Dividend Pay Date 2019-07-11
Ex-Dividend Date 2019-05-16
Forward Dividend 1.980
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.